VANESSA PEDREGO: Open Payments
NPI 1467763755 · POMONA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,376 in 68 payments from 21 companies in 2025. Trend: 2023 $1,641 · 2024 $1,032 · 2025 $1,376
Food & beverage: $1,376
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 17 | $203 |
| Novo Nordisk Inc | 8 | $168 |
| Lilly USA, LLC | 7 | $141 |
| Tandem Diabetes Care, Inc. | 4 | $105 |
| Abbott Laboratories | 5 | $101 |
| Ionis Pharmaceuticals, Inc. | 3 | $78 |
| Novartis Pharmaceuticals Corporation | 3 | $73 |
| Radius Health, Inc. | 3 | $73 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $70 |
| Corcept Therapeutics | 2 | $49 |
Products named: TEPEZZA, JARDIANCE, t:slim X2 Insulin Pump with Control-IQ, FREESTYLE LIBRE 3, MOUNJARO, TRYNGOLZA, Ozempic, Korlym.
Industry payments across CA — which companies pay providers there.
